Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Emergence of Kaposi's Sarcoma Herpesvirus-Associated Complications Following Corticosteroid Use in TB-IRIS.

Manion M, Uldrick T, Polizzotto MN, Sheikh V, Roby G, Lurain K, Metzger D, Mican JM, Pau A, Lisco A, Laidlaw E, Hammoud DA, Whitby D, Yarchoan R, Sereti I.

Open Forum Infect Dis. 2018 Oct 12;5(10):ofy217. doi: 10.1093/ofid/ofy217. eCollection 2018 Oct.

2.

Increased Metabolic Activity on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Human Immunodeficiency Virus-Associated Immune Reconstitution Inflammatory Syndrome.

Hammoud DA, Boulougoura A, Papadakis GZ, Wang J, Dodd LE, Rupert A, Higgins J, Roby G, Metzger D, Laidlaw E, Mican JM, Pau A, Lage S, Wong CS, Lisco A, Manion M, Sheikh V, Millo C, Sereti I.

Clin Infect Dis. 2019 Jan 7;68(2):229-238. doi: 10.1093/cid/ciy454.

PMID:
30215671
3.

Graves' disease as immune reconstitution disease in HIV-positive patients is associated with naive and primary thymic emigrant CD4(+) T-cell recovery.

Sheikh V, Dersimonian R, Richterman AG, Porter BO, Natarajan V, Burbelo PD, Rupert A, Santich BH, Kardava L, Mican JM, Moir S, Sereti I.

AIDS. 2014 Jan 2;28(1):31-9. doi: 10.1097/QAD.0000000000000006.

PMID:
23939238
4.

Microalbuminuria in HIV disease.

Hadigan C, Edwards E, Rosenberg A, Purdy JB, Fleischman E, Howard L, Mican JM, Sampath K, Oyalowo A, Johnson A, Adler A, Rehm C, Smith M, Lai L, Kopp JB.

Am J Nephrol. 2013;37(5):443-51. doi: 10.1159/000350384. Epub 2013 Apr 20.

5.

Decreases in IL-7 levels during antiretroviral treatment of HIV infection suggest a primary mechanism of receptor-mediated clearance.

Hodge JN, Srinivasula S, Hu Z, Read SW, Porter BO, Kim I, Mican JM, Paik C, Degrange P, Di Mascio M, Sereti I.

Blood. 2011 Sep 22;118(12):3244-53. doi: 10.1182/blood-2010-12-323600. Epub 2011 Jul 21.

6.

Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV.

Musselwhite LW, Sheikh V, Norton TD, Rupert A, Porter BO, Penzak SR, Skinner J, Mican JM, Hadigan C, Sereti I.

AIDS. 2011 Mar 27;25(6):787-95. doi: 10.1097/QAD.0b013e3283453fcb.

7.

Conducting HIV research in racial and ethnic minority communities: building a successful interdisciplinary research team.

Polanco FR, Dominguez DC, Grady C, Stoll P, Ramos C, Mican JM, Miranda-Acevedo R, Morgan M, Aizvera J, Purdie L, Koziol D, Rivera-Goba MV.

J Assoc Nurses AIDS Care. 2011 Sep-Oct;22(5):388-96. doi: 10.1016/j.jana.2010.10.008. Epub 2011 Feb 1. Review.

8.

Exploring decision-making of HIV-infected Hispanics and African Americans participating in clinical trials.

Rivera-Goba MV, Dominguez DC, Stoll P, Grady C, Ramos C, Mican JM.

J Assoc Nurses AIDS Care. 2011 Jul-Aug;22(4):295-306. doi: 10.1016/j.jana.2010.10.007. Epub 2011 Jan 21.

9.

Clinical evaluation of the potential utility of computational modeling as an HIV treatment selection tool by physicians with considerable HIV experience.

Larder BA, Revell A, Mican JM, Agan BK, Harris M, Torti C, Izzo I, Metcalf JA, Rivera-Goba M, Marconi VC, Wang D, Coe D, Gazzard B, Montaner J, Lane HC.

AIDS Patient Care STDS. 2011 Jan;25(1):29-36. doi: 10.1089/apc.2010.0254.

10.

Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy.

Migueles SA, Weeks KA, Nou E, Berkley AM, Rood JE, Osborne CM, Hallahan CW, Cogliano-Shutta NA, Metcalf JA, McLaughlin M, Kwan R, Mican JM, Davey RT Jr, Connors M.

J Virol. 2009 Nov;83(22):11876-89. doi: 10.1128/JVI.01153-09. Epub 2009 Sep 2.

11.

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy.

Dinoso JB, Kim SY, Wiegand AM, Palmer SE, Gange SJ, Cranmer L, O'Shea A, Callender M, Spivak A, Brennan T, Kearney MF, Proschan MA, Mican JM, Rehm CA, Coffin JM, Mellors JW, Siliciano RF, Maldarelli F.

Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9403-8. doi: 10.1073/pnas.0903107106. Epub 2009 May 22.

12.

Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir.

Ramanathan R, Pau AK, Busse KH, Zemskova M, Nieman L, Kwan R, Hammer JH, Mican JM, Maldarelli F.

Clin Infect Dis. 2008 Dec 15;47(12):e97-9. doi: 10.1086/593314.

13.

Identification of novel markers for liver fibrosis in HIV/hepatitis C virus coinfected individuals using genomics-based approach.

Suzman DL, McLaughlin M, Hu Z, Kleiner DE, Wood B, Lempicki RA, Mican JM, Suffredini A, Masur H, Polis MA, Kottilil S.

AIDS. 2008 Jul 31;22(12):1433-9. doi: 10.1097/QAD.0b013e328304dfe7.

14.

Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.

Chun TW, Nickle DC, Justement JS, Meyers JH, Roby G, Hallahan CW, Kottilil S, Moir S, Mican JM, Mullins JI, Ward DJ, Kovacs JA, Mannon PJ, Fauci AS.

J Infect Dis. 2008 Mar 1;197(5):714-20. doi: 10.1086/527324.

PMID:
18260759
15.

Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro.

Tilton JC, Manion MM, Luskin MR, Johnson AJ, Patamawenu AA, Hallahan CW, Cogliano-Shutta NA, Mican JM, Davey RT Jr, Kottilil S, Lifson JD, Metcalf JA, Lempicki RA, Connors M.

J Virol. 2008 Apr;82(8):3997-4006. doi: 10.1128/JVI.01545-07. Epub 2008 Feb 6.

16.

Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease.

Moir S, Malaspina A, Ho J, Wang W, Dipoto AC, O'Shea MA, Roby G, Mican JM, Kottilil S, Chun TW, Proschan MA, Fauci AS.

J Infect Dis. 2008 Feb 15;197(4):572-9. doi: 10.1086/526789.

PMID:
18240953
17.

Progressive outer retinal necrosis in the era of highly active antiretroviral therapy: successful management with intravitreal injections and monitoring with quantitative PCR.

Yin PD, Kurup SK, Fischer SH, Rhee HH, Byrnes GA, Levy-Clarke GA, Buggage RR, Nussenblatt RB, Mican JM, Wright ME.

J Clin Virol. 2007 Mar;38(3):254-9. Epub 2007 Feb 5.

PMID:
17280866
18.

The incidence and natural history of osteonecrosis in HIV-infected adults.

Morse CG, Mican JM, Jones EC, Joe GO, Rick ME, Formentini E, Kovacs JA.

Clin Infect Dis. 2007 Mar 1;44(5):739-48. Epub 2007 Jan 23.

PMID:
17278070
19.

Two overrepresented B cell populations in HIV-infected individuals undergo apoptosis by different mechanisms.

Ho J, Moir S, Malaspina A, Howell ML, Wang W, DiPoto AC, O'Shea MA, Roby GA, Kwan R, Mican JM, Chun TW, Fauci AS.

Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19436-41. Epub 2006 Dec 8.

20.

Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons.

Tilton JC, Johnson AJ, Luskin MR, Manion MM, Yang J, Adelsberger JW, Lempicki RA, Hallahan CW, McLaughlin M, Mican JM, Metcalf JA, Iyasere C, Connors M.

J Virol. 2006 Dec;80(23):11486-97. Epub 2006 Sep 27.

21.

Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7.

Malaspina A, Moir S, Ho J, Wang W, Howell ML, O'Shea MA, Roby GA, Rehm CA, Mican JM, Chun TW, Fauci AS.

Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2262-7. Epub 2006 Feb 6.

22.

A potentially significant interaction between efavirenz and phenytoin: a case report and review of the literature.

Robertson SM, Penzak SR, Lane J, Pau AK, Mican JM.

Clin Infect Dis. 2005 Jul 15;41(2):e15-8. Epub 2005 Jun 7. Review.

PMID:
15983905
23.

Compromised B cell responses to influenza vaccination in HIV-infected individuals.

Malaspina A, Moir S, Orsega SM, Vasquez J, Miller NJ, Donoghue ET, Kottilil S, Gezmu M, Follmann D, Vodeiko GM, Levandowski RA, Mican JM, Fauci AS.

J Infect Dis. 2005 May 1;191(9):1442-50. Epub 2005 Mar 24.

PMID:
15809902
24.

Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.

Moir S, Malaspina A, Pickeral OK, Donoghue ET, Vasquez J, Miller NJ, Krishnan SR, Planta MA, Turney JF, Justement JS, Kottilil S, Dybul M, Mican JM, Kovacs C, Chun TW, Birse CE, Fauci AS.

J Exp Med. 2004 Oct 4;200(7):587-99. Erratum in: J Exp Med. 2004 Oct 4;200(7): following 946.

PMID:
15508184
25.

Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.

Moir S, Malaspina A, Pickeral OK, Donoghue ET, Vasquez J, Miller NJ, Krishnan SR, Planta MA, Turney JF, Justement JS, Kottilil S, Dybul M, Mican JM, Kovacs C, Chun TW, Birse CE, Fauci AS.

J Exp Med. 2004 Sep 6;200(5):587-99. Corrected and republished in: J Exp Med. 2004 Oct 4;200(7):587-99.

26.

New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma.

Palmer S, Wiegand AP, Maldarelli F, Bazmi H, Mican JM, Polis M, Dewar RL, Planta A, Liu S, Metcalf JA, Mellors JW, Coffin JM.

J Clin Microbiol. 2003 Oct;41(10):4531-6.

27.

Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen.

Polis MA, Suzman DL, Yoder CP, Shen JM, Mican JM, Dewar RL, Metcalf JA, Falloon J, Davey RT Jr, Kovacs JA, Feinberg MB, Masur H, Piscitelli SC.

AIDS. 2003 May 23;17(8):1167-72.

PMID:
12819518
28.

Increasing CD4+ T cells specific for tuberculosis correlate with improved clinical immunity after highly active antiretroviral therapy.

Hengel RL, Allende MC, Dewar RL, Metcalf JA, Mican JM, Lane HC.

AIDS Res Hum Retroviruses. 2002 Sep 1;18(13):969-75.

PMID:
12230939
29.

High prevalence of osteonecrosis of the femoral head in HIV-infected adults.

Miller KD, Masur H, Jones EC, Joe GO, Rick ME, Kelly GG, Mican JM, Liu S, Gerber LH, Blackwelder WC, Falloon J, Davey RT, Polis MA, Walker RE, Lane HC, Kovacs JA.

Ann Intern Med. 2002 Jul 2;137(1):17-25.

PMID:
12093241
30.

Indinavir-associated interstitial nephritis and urothelial inflammation: clinical and cytologic findings.

Kopp JB, Falloon J, Filie A, Abati A, King C, Hortin GL, Mican JM, Vaughan E, Miller KD.

Clin Infect Dis. 2002 Apr 15;34(8):1122-8. Epub 2002 Mar 15.

PMID:
11915002
31.

Diagnosis of avascular necrosis of the hip in asymptomatic HIV-infected patients: Clinical correlation of physical examination with magnetic resonance imaging.

Joe GO, Kovacs JA, Miller KD, Kelly GG, Koziol DE, Jones EC, Mican JM, Masur H, Gerber L.

J Back Musculoskelet Rehabil. 2002 Jan 1;16(4):135-9.

PMID:
22387437
32.

Alopecia universalis and Graves' disease in the setting of immune restoration after highly active antiretroviral therapy.

Sereti I, Sarlis NJ, Arioglu E, Turner ML, Mican JM.

AIDS. 2001 Jan 5;15(1):138-40. No abstract available.

PMID:
11192862
33.

Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.

Chun TW, Justement JS, Moir S, Hallahan CW, Ehler LA, Liu S, McLaughlin M, Dybul M, Mican JM, Fauci AS.

Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):253-8.

34.

Longitudinal changes in CD4+ T cell antigen receptor diversity and naive/memory cell phenotype during 9 to 26 months of antiretroviral therapy of HIV-infected patients.

Gea-Banacloche JC, Martino L, Mican JM, Hallahan CW, Baseler M, Stevens R, Lambert L, Polis M, Lane HC, Connors M.

AIDS Res Hum Retroviruses. 2000 Nov 20;16(17):1877-86.

PMID:
11118073
35.
36.

Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor--sparing highly active antiretroviral therapy.

Dybul M, Chun TW, Ward DJ, Hertogs K, Larder B, Fox CH, Orenstein JM, Baird BF, Li Y, Green LG, Engel D, Liu S, Mican JM, Fauci AS.

J Infect Dis. 2000 Apr;181(4):1273-9.

PMID:
10836864
37.

Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient.

Orenstein JM, Feinberg M, Yoder C, Schrager L, Mican JM, Schwartzentruber DJ, Davey RT Jr, Walker RE, Falloon J, Kovacs JA, Miller KD, Fox C, Metcalf JA, Masur H, Polis MA.

AIDS. 1999 Nov 12;13(16):2219-29.

PMID:
10563707
38.

Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy.

Chun TW, Engel D, Mizell SB, Hallahan CW, Fischette M, Park S, Davey RT Jr, Dybul M, Kovacs JA, Metcalf JA, Mican JM, Berrey MM, Corey L, Lane HC, Fauci AS.

Nat Med. 1999 Jun;5(6):651-5.

PMID:
10371503
39.

Progression of human immunodeficiency virus disease is associated with increasing disruptions within the CD4+ T cell receptor repertoire.

Gea-Banacloche JC, Weiskopf EE, Hallahan C, López Bernaldo de Quirós JC, Flanigan M, Mican JM, Falloon J, Baseler M, Stevens R, Lane HC, Connors M.

J Infect Dis. 1998 Mar;177(3):579-85.

PMID:
9498435
40.

Systemic mastocytosis: CT and US features of abdominal manifestations.

Avila NA, Ling A, Worobec AS, Mican JM, Metcalfe DD.

Radiology. 1997 Feb;202(2):367-72.

PMID:
9015059
41.

Hepatic involvement in mastocytosis: clinicopathologic correlations in 41 cases.

Mican JM, Di Bisceglie AM, Fong TL, Travis WD, Kleiner DE, Baker B, Metcalfe DD.

Hepatology. 1995 Oct;22(4 Pt 1):1163-70.

PMID:
7557867
42.
43.

Radiotherapy of refractory bone pain due to systemic mast cell disease.

Johnstone PA, Mican JM, Metcalfe DD, DeLaney TF.

Am J Clin Oncol. 1994 Aug;17(4):328-30.

PMID:
7519391
44.

Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells.

Kirshenbaum AS, Goff JP, Kessler SW, Mican JM, Zsebo KM, Metcalfe DD.

J Immunol. 1992 Feb 1;148(3):772-7.

PMID:
1370517
45.

Arthritis and mast cell activation.

Mican JM, Metcalfe DD.

J Allergy Clin Immunol. 1990 Oct;86(4 Pt 2):677-83. Review.

PMID:
2229835

Supplemental Content

Loading ...
Support Center